MA43151A - Anticorps monoclonaux spécifiques pour le sérogroupe x de n. meningitidis et leurs utilisations dans le diagnostic - Google Patents

Anticorps monoclonaux spécifiques pour le sérogroupe x de n. meningitidis et leurs utilisations dans le diagnostic

Info

Publication number
MA43151A
MA43151A MA043151A MA43151A MA43151A MA 43151 A MA43151 A MA 43151A MA 043151 A MA043151 A MA 043151A MA 43151 A MA43151 A MA 43151A MA 43151 A MA43151 A MA 43151A
Authority
MA
Morocco
Prior art keywords
diagnosis
monoclonal antibodies
specific monoclonal
meningitidis serogroup
serogroup
Prior art date
Application number
MA043151A
Other languages
English (en)
Other versions
MA43151B1 (fr
Inventor
Alain Agnememel
Muhamed-Kheir Taha
Original Assignee
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut filed Critical Pasteur Institut
Publication of MA43151A publication Critical patent/MA43151A/fr
Publication of MA43151B1 publication Critical patent/MA43151B1/fr

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203Gram-negative bacteria
    • C07K16/1217Neisseriaceae (F)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/10Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14Specific host cells or culture conditions, e.g. components, pH or temperature
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/30Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/33Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565Complementarity determining region [CDR]
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/22Assays involving biological materials from specific organisms or of a specific nature from bacteria from Neisseriaceae (F), e.g. Acinetobacter
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00Immunoassays for the detection of microorganisms
    • G01N2469/10Detection of antigens from microorganism in sample from host
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/26Infectious diseases, e.g. generalised sepsis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
MA43151A 2015-06-09 2016-06-08 Anticorps monoclonaux spécifiques pour le sérogroupe x de n. meningitidis et leurs utilisations dans le diagnostic MA43151B1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15305877 2015-06-09
PCT/EP2016/062994 WO2016198435A1 (fr) 2015-06-09 2016-06-08 Anticorps monoclonaux spécifiques pour le sérogroupe x de n. meningitidis et leurs utilisations dans le diagnostic
EP16727523.9A EP3307774B1 (fr) 2015-06-09 2016-06-08 Anticorps monoclonaux spécifiques pour le sérogroupe x de n. meningitidis et leurs utilisations dans le diagnostic

Publications (2)

Publication Number Publication Date
MA43151A true MA43151A (fr) 2021-05-12
MA43151B1 MA43151B1 (fr) 2025-06-30

Family

ID=53365948

Family Applications (1)

Application Number Title Priority Date Filing Date
MA43151A MA43151B1 (fr) 2015-06-09 2016-06-08 Anticorps monoclonaux spécifiques pour le sérogroupe x de n. meningitidis et leurs utilisations dans le diagnostic

Country Status (5)

Country Link
US (1) US10613085B2 (fr)
EP (1) EP3307774B1 (fr)
ES (1) ES3024468T3 (fr)
MA (1) MA43151B1 (fr)
WO (1) WO2016198435A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9458450B2 (en) 2012-03-15 2016-10-04 Flodesign Sonics, Inc. Acoustophoretic separation technology using multi-dimensional standing waves
US10704021B2 (en) 2012-03-15 2020-07-07 Flodesign Sonics, Inc. Acoustic perfusion devices
WO2015105955A1 (fr) 2014-01-08 2015-07-16 Flodesign Sonics, Inc. Dispositif d'acoustophorèse avec double chambre acoustophorétique
BR112017009931A2 (pt) 2014-11-18 2018-02-14 Pasteur Institut anticorpos policlonais, agente de diagnóstico, método de detecção de sorogrupo x de neisseria meningitidis in vitro, método in vitro de diagnóstico de infecção no sorogrupo x de neisseria meningitidis, kit e teste de diagnóstico, uso do kit de diagnóstico e método de produção de anticorpos policlonais
US11708572B2 (en) 2015-04-29 2023-07-25 Flodesign Sonics, Inc. Acoustic cell separation techniques and processes
US11377651B2 (en) 2016-10-19 2022-07-05 Flodesign Sonics, Inc. Cell therapy processes utilizing acoustophoresis
US11474085B2 (en) 2015-07-28 2022-10-18 Flodesign Sonics, Inc. Expanded bed affinity selection
US11459540B2 (en) 2015-07-28 2022-10-04 Flodesign Sonics, Inc. Expanded bed affinity selection
US11214789B2 (en) 2016-05-03 2022-01-04 Flodesign Sonics, Inc. Concentration and washing of particles with acoustics
US11085035B2 (en) 2016-05-03 2021-08-10 Flodesign Sonics, Inc. Therapeutic cell washing, concentration, and separation utilizing acoustophoresis
KR102439221B1 (ko) 2017-12-14 2022-09-01 프로디자인 소닉스, 인크. 음향 트랜스듀서 구동기 및 제어기
WO2020160157A1 (fr) * 2019-01-30 2020-08-06 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Détection de complexes hétérodimères de la famille bcl-2 et utilisation associée
CN109879961B (zh) * 2019-03-26 2022-04-26 天津喜诺生物医药有限公司 一种抗隐球菌荚膜多糖单克隆抗体及其杂交瘤细胞株制备与应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112017009931A2 (pt) 2014-11-18 2018-02-14 Pasteur Institut anticorpos policlonais, agente de diagnóstico, método de detecção de sorogrupo x de neisseria meningitidis in vitro, método in vitro de diagnóstico de infecção no sorogrupo x de neisseria meningitidis, kit e teste de diagnóstico, uso do kit de diagnóstico e método de produção de anticorpos policlonais

Also Published As

Publication number Publication date
US20180180610A1 (en) 2018-06-28
ES3024468T3 (en) 2025-06-04
WO2016198435A1 (fr) 2016-12-15
EP3307774A1 (fr) 2018-04-18
US10613085B2 (en) 2020-04-07
EP3307774B1 (fr) 2025-04-30
MA43151B1 (fr) 2025-06-30
EP3307774C0 (fr) 2025-04-30

Similar Documents

Publication Publication Date Title
MA43151A (fr) Anticorps monoclonaux spécifiques pour le sérogroupe x de n. meningitidis et leurs utilisations dans le diagnostic
FR23C1012I2 (fr) Anticorps anti-bcma, molécules bispécifiques de liaison à un antigène liant bcma et cd3 et leurs utilisations
FR24C1023I2 (fr) Anticorps thérapeutiques et leurs utilisations
EP3389699A4 (fr) Anticorps monoclonaux chimériques et humanisés anti-ctla4 humaine, et leurs utilisations
MA53184A (fr) Anticorps anti-ox40 et leurs utilisations
MA49687A (fr) Anticorps anti-ctla-4 et leurs utilisations
MA52773A (fr) Anticorps anti-cd3 et leurs utilisations
EP3411069A4 (fr) Anticorps humanisés anti-cd3, conjugués et leurs utilisations
EP3377102A4 (fr) Anticorps anti-pd-1 et leurs utilisations thérapeutiques
MA43389A (fr) Anticorps anti-ox40 et leurs procédés d'utilisation
MA46770A (fr) Anticorps anti-ox40, anticorps anti-gitr, et leurs procédés d'utilisation
MA52949A (fr) Anticorps anti-pd-1 et leurs utilisations
EP3426686A4 (fr) Anticorps anti-pacap humanisés et leurs utilisations
EP3328895A4 (fr) Anticorps anti-pd-l1 et leurs utilisations
MA46708A (fr) Anticorps anti-pd1 et leurs utilisations
EP3386536A4 (fr) Composition de conjugués d'agonistes-constructions d'anticorps et leurs procédés d'utilisation
MA42447A (fr) Anticorps anti-pd-1, anticorps anti-pd-1 activables, et leurs procédés d'utilisation
EP2970494A4 (fr) Anticorps monoclonaux spécifiques de her3 pour l'utilisation dans le diagnostic et thérapeutique
EP3356416A4 (fr) Anticorps anti-pd-1 et ses utilisations
MA49537A (fr) Anticorps anti-lag3 et leurs utilisations
MA46704A (fr) Anticorps anti-pyroglutamate- amyloïde-beta et leurs utilisations
EP3443012A4 (fr) Anticorps anti-axl, fragments d'anticorps et leurs immunoconjugués et utilisations associées
MA45125A (fr) Anticorps anti-alpha-synucléine et leurs utilisations
MA45233A (fr) Anticorps anti-gitr et leurs utilisations
EP3661555A4 (fr) Anticorps bispécifiques et leurs utilisations